Your browser is no longer supported. Please, upgrade your browser.
MRNA Moderna, Inc. daily Stock Chart
Moderna, Inc.
Index- P/E- EPS (ttm)-1.61 Insider Own2.90% Shs Outstand364.91M Perf Week-4.28%
Market Cap6.65B Forward P/E- EPS next Y-1.61 Insider Trans-14.53% Shs Float279.07M Perf Month-17.02%
Income-535.00M PEG- EPS next Q-0.42 Inst Own49.10% Short Float6.72% Perf Quarter-5.84%
Sales81.60M P/S81.52 EPS this Y-46.90% Inst Trans3.57% Short Ratio5.62 Perf Half Y27.57%
Book/sh3.78 P/B4.82 EPS next Y-5.20% ROA-30.40% Target Price29.78 Perf Year-5.74%
Cash/sh2.90 P/C6.28 EPS next 5Y16.80% ROE-38.40% 52W Range11.54 - 29.79 Perf YTD-6.80%
Dividend- P/FCF- EPS past 5Y- ROI-26.40% 52W High-38.80% Beta-
Dividend %- Quick Ratio7.40 Sales past 5Y- Gross Margin- 52W Low57.97% ATR1.29
Employees760 Current Ratio7.40 Sales Q/Q-59.30% Oper. Margin- RSI (14)39.17 Volatility3.39% 6.25%
OptionableYes Debt/Eq0.03 EPS Q/Q-37.60% Profit Margin- Rel Volume1.09 Prev Close18.54
ShortableYes LT Debt/Eq0.03 EarningsFeb 26 BMO Payout- Avg Volume3.34M Price18.23
Recom1.80 SMA20-11.63% SMA50-8.19% SMA2004.25% Volume3,650,313 Change-1.67%
Dec-03-19Resumed BofA/Merrill Buy
Oct-25-19Initiated ROTH Capital Buy $24
Apr-05-19Initiated Chardan Capital Markets Buy $40
Feb-23-20 12:26PM  Notable Insider Buys Last Week: Moderna, Tesla And More Benzinga
Feb-21-20 09:21AM  Moderna (MRNA) to Report Q4 Earnings: What's in the Cards? Zacks
05:55AM  These are the steps needed for a vaccine to be approved MarketWatch
Feb-19-20 05:45PM  Moderna (MRNA) Gains But Lags Market: What You Should Know Zacks
10:35AM  Revolution Medicines Joins Amgen and Mirati in Quest for New Type of Cancer Drugs
Feb-18-20 09:27AM  How a small S.F. design-build software firm could help unlock a coronavirus vaccine American City Business Journals
Feb-12-20 04:30PM  Moderna to Report Fourth Quarter and Full Year 2019 Financial Results on Wednesday, February 26th, 2020 Business Wire -10.96%
04:11PM  How A Two-Day Plunge Wiped Out This Biotech's Coronavirus Gains Investor's Business Daily
09:30AM  3 Coronavirus Stocks to Snap Up Now TipRanks
Feb-11-20 10:12PM  Moderna Announces Pricing of Public Offering of Shares of Common Stock Business Wire -9.73%
06:11PM  Andreas Halvorsen Plunges Into aTyr Pharma
04:15PM  Why This Highflying Biotech Hit The Skids After Its Vaccine Update Investor's Business Daily
02:18PM  Coronavirus update: 1,018 deaths, a new case in San Diego, 195 evacuees expected to leave quarantine MarketWatch
11:30AM  Is Moderna (MRNA) Stock Outpacing Its Medical Peers This Year? Zacks
Feb-10-20 05:45PM  Moderna (MRNA) Outpaces Stock Market Gains: What You Should Know Zacks
05:11PM  Moderna Announces Progress in Prophylactic Vaccines Modality with CMV Vaccine Phase 2 Study Data Now Expected in Third Quarter 2020 and Expands Investment in This Core Modality with Three New Development Candidates Business Wire
05:10PM  Moderna Announces First Patient Enrolled in Phase 1/2 Study of mRNA-3704 for Methylmalonic Acidemia Business Wire
04:13PM  Moderna Announces Proposed Public Offering of Shares of Common Stock Business Wire
Feb-07-20 04:06PM  No Glitches in Early Effort for Coronavirus Vaccine, NIH Says. Moderna Stock Is Flying. +16.90%
03:07PM  Moderna's stock jumps as health officials say virus vaccine development has 'no glitches' MarketWatch
09:52AM  Breaking: Moderna Jumps on Coronavirus Vaccine Progress
Feb-06-20 05:50PM  Can Biotech ETFs Continue to Soar in 2020? Zacks
Feb-05-20 03:19PM  FOCUS-Drugmakers see long road ahead in coronavirus vaccine race Reuters
Feb-04-20 06:41PM  Should Growth Investors Buy this Cancer Screening Biotech Stock? Zacks
01:19PM  Coronavirus update: China toll skyrockets, but markets calm amid government cash infusion Yahoo Finance
Feb-03-20 05:45PM  Moderna (MRNA) Stock Sinks As Market Gains: What You Should Know Zacks
02:48PM  Here's how two local biotechs plan to have a coronavirus vaccine within just a few months American City Business Journals
11:27AM  Andreas Halvorsen Trims Adaptive Biotechnologies Stake
08:00AM  Sandra Horning, M.D. To Join Modernas Board of Directors Business Wire
Feb-01-20 10:53AM  Coronavirus update: WHO says prepare for local coronavirus outbreaks in other countries MarketWatch
Jan-31-20 01:20PM  Here's What Biotech Companies Are Doing To Combat The Coronavirus Investor's Business Daily
10:52AM  Some Drugmakers Are Racing to Develop a Coronavirus Vaccine. Why Big Pharma Isnt Rushing In.
Jan-30-20 06:21PM  J&J (JNJ) Plans to Develop Vaccine for New Coronavirus Zacks
12:36PM  Coronavirus: How Fast to 100,000 Infected? Zacks
08:00AM  Melanie Ivarsson, Ph.D. Joins Moderna as Chief Development Officer Business Wire
Jan-29-20 04:11PM  Coronavirus: Epidemic or Pandemic? Zacks -8.09%
01:40PM  Coronavirus update: Vaccine expected in Phase 1 trial within months, WHO to reconvene on Thursday MarketWatch
08:50AM  Implied Volatility Surging for Moderna (MRNA) Stock Options Zacks
Jan-28-20 02:23PM  Coronavirus update: Vaccine stocks retreat and airport screening expands to 20 U.S. airports MarketWatch
01:35PM  Wining & Losing ETF Areas on Coronavirus Outbreak Zacks
05:34AM  Moderna Could Rally Further Amid Coronavirus Concerns
Jan-27-20 04:42PM  3 Biotech Stocks Are Soaring Because Everyone Wants a Coronavirus Vaccine +7.67%
04:03PM  Stock market news live: Stocks close lower as coronavirus death toll rises Yahoo Finance
02:21PM  CDC officials say coronavirus is similar to SARS, no new U.S. cases reported MarketWatch
10:58AM  Analyst: China's coronavirus victims 'probably 10 times' higher than reported Yahoo Finance
06:02AM  RPT-With Wuhan virus genetic code in hand, scientists begin work on a vaccine Reuters
Jan-25-20 10:58AM  Second coronavirus patient identified, extent and duration of airport screening to be re-evaluated MarketWatch
Jan-24-20 04:46PM  With Wuhan virus genetic code in hand, scientists begin work on a vaccine Reuters
03:08PM  Biotech ETFs Are Not Riding the Wave from Coronavirus Panic ETF Trends
08:59AM  Coronavirus Spooks Global Markets: Winners and Losers Zacks
08:55AM  CEPI Grant, Government Aid Drive Coronavirus Focused Biotechs Zacks
01:00AM  PRESS DIGEST -Wall Street Journal - Jan 24 Reuters
Jan-23-20 01:02PM  13 Coronavirus-Related Stocks To Watch Amid Wuhan Outbreak Benzinga
11:01AM  UPDATE: Vaccine stocks rise sharply as coronavirus fears mounts MarketWatch
10:35AM  Company News for Jan 23, 2020 Zacks
10:18AM  3 Biotech Stocks Likely to Gain as Coronavirus Spreads Zacks
09:15AM  Moderna Announces Funding Award from CEPI to Accelerate Development of Messenger RNA (mRNA) Vaccine Against Novel Coronavirus Business Wire
09:00AM  Epidemic response group says starts work on 3 possible China virus vaccines Reuters
06:54AM  Outbreak Sparks Biotech Booms But Vaccine Funding Is Missing Bloomberg
06:54AM  Vaccine makers tap into virus-driven rally to raise money MarketWatch
Jan-22-20 12:18PM  Moderna Stock Is Jumping as Company Hunts a Quick Vaccine for Chinese Virus
11:30AM  Is Moderna (MRNA) Outperforming Other Medical Stocks This Year? Zacks
05:42AM  Moderna, National Institutes of Health Join to Develop Coronavirus Vaccine
Jan-13-20 02:30PM  'We will deliver in 2020,' Cambridge biotech CEO promises after 2nd trial disappointment American City Business Journals +5.85%
Jan-12-20 02:00PM  Moderna Builds on Clinical Validation of Systemic Delivery with Two Additional Development Candidates in New Autoimmune Therapeutic Area Business Wire
Jan-10-20 11:04AM  Moderna Stock Takes Off After Good News for Its Birth-Defect Vaccine
07:13AM  The Daily Biotech Pulse: Positive Data Readouts To Spur Aclaris, Moderna And Ultragenyx Benzinga
Jan-09-20 04:01PM  Moderna Sees Positive Results on Vaccine for Disease That Can Cause Birth Defects
04:01PM  Moderna Announces Additional Positive Phase 1 Data from Cytomegalovirus (CMV) Vaccine (mRNA-1647) and First Participant Dosed in Phase 2 Study Business Wire
Jan-06-20 08:30AM  Moderna to Provide Business and Pipeline Updates at the 2020 J.P. Morgan Healthcare Conference Business Wire
Dec-19-19 05:51PM  4 More Biotechs With Blockbuster Potential
11:45AM  Did You Miss Moderna's (NASDAQ:MRNA) 20% Share Price Gain? Simply Wall St.
08:00AM  Flagship Unveils Newest Pioneering Platform: Ring Therapeutics PR Newswire
Dec-16-19 09:34AM  5 Biotech Stocks Set for Continued Rally in 2020 Zacks
06:12AM  Did Hedge Funds Drop The Ball On Moderna, Inc. (MRNA) ? Insider Monkey
Dec-11-19 08:00AM  Moderna Announces Key 2020 Investor and Analyst Events Business Wire
Dec-10-19 03:06PM  Moderna to expand in Norwood, plans to transfer 250 jobs from Cambridge American City Business Journals
08:00AM  François Nader, M.D., Joins Modernas Board of Directors Business Wire
Nov-30-19 02:59PM  Hedge Funds Are Way More Bullish On PG&E Corp Than These Stocks Insider Monkey
Nov-26-19 08:00AM  Moderna to Present at 31st Annual Piper Jaffray Healthcare Conference Business Wire
Nov-25-19 09:22AM  The Zacks Analyst Blog Highlights: Alteryx, Moderna, Car-Mart, Bloom Energy and Target Zacks
Nov-22-19 07:15AM  5 Top Stocks That Surged Amid Volatility in the Last 7 Days Zacks
Nov-14-19 10:25AM  Moderna, Inc. (MRNA) Shares March Higher, Can It Continue? Zacks
Nov-13-19 02:32PM  Ex-Novartis exec named as Flagship's matchmaker for Big Pharma partnerships American City Business Journals
Nov-08-19 09:38AM  Top Ranked Momentum Stocks to Buy for November 8th Zacks
Nov-06-19 07:00AM  Moderna Provides Business Updates and Reports Third Quarter 2019 Financial Results Business Wire
Nov-05-19 08:00AM  Moderna to Present at Credit Suisse 28th Annual Healthcare Conference Business Wire
06:43AM  3 Hot Biotech Stocks With 100% Street Support TipRanks
Oct-24-19 02:21PM  Moderna Named Top Employer by Science for Fifth Consecutive Year Business Wire
11:06AM  Hedge Funds Have Never Been This Bullish On Moderna, Inc. (MRNA) Insider Monkey
Oct-23-19 07:54AM  The Daily Biotech Pulse: Eli Lily Revenues Trail Estimates, Moderna Gets Fast Track Designation, MacroGenics' Lukewarm Breast Cancer Data Benzinga +6.16%
Oct-22-19 04:15PM  Moderna Receives FDA Fast Track Designation for Propionic Acidemia Program (mRNA-3927) Business Wire
08:00AM  Moderna to Report Third Quarter 2019 Financial Results on Wednesday, November 6th, 2019 Business Wire
Oct-03-19 05:53PM  Moderna, Allogene Have Disappointed Investors
Oct-02-19 07:00AM  Moderna to Present Data From Two of Its Prophylactic mRNA Vaccines at IDWeek 2019 Business Wire
Sep-30-19 08:00AM  Moderna Announces Open IND for Propionic Acidemia Program (mRNA-3927) Business Wire
Sep-26-19 08:00AM  Moderna Announces mRNA Immunotherapy Research Collaboration with Harvard University Business Wire
Sep-25-19 08:00AM  Moderna to Present at Upcoming Investor Conferences Business Wire
Sep-23-19 05:54AM  3 Biotech Stocks Surging on Positive Results TipRanks
Sep-20-19 09:33AM  What Kind Of Investor Owns Most Of Moderna, Inc. (NASDAQ:MRNA)? Simply Wall St.
Moderna, Inc., a clinical stage biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, and cardiovascular diseases. As of February 15, 2019 the company had 11 programs in clinical trials and a total of 20 development candidates in six modalities comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. It has strategic alliances with AstraZeneca, Merck & Co., Vertex Pharmaceuticals, Biomedical Advanced Research and Development Authority, Defense Advanced Research Projects Agency, and Bill & Melinda Gates Foundation; and a research collaboration with Harvard University. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SAGAN PAULDirectorFeb 14Buy19.0052,631999,989420,407Feb 18 04:09 PM
Bancel StephaneChief Executive OfficerFeb 14Sale19.0211,046210,095740,098Feb 18 04:07 PM
Hoge StephenPresidentFeb 13Sale19.235,00096,1502,066,530Feb 14 04:25 PM
Hoge StephenPresidentFeb 12Sale19.445,00097,2002,071,530Feb 14 04:25 PM
Bancel StephaneChief Executive OfficerFeb 10Sale23.5012,909303,3627,955,859Feb 11 09:51 PM
Bancel StephaneChief Executive OfficerFeb 10Sale23.504,303101,1216,732,934Feb 11 09:51 PM
Kim Lorence H.Chief Financial OfficerFeb 07Sale23.0633,295767,7831,302,510Feb 11 09:52 PM
Bancel StephaneChief Executive OfficerFeb 07Sale21.1811,046233,952751,144Feb 11 09:51 PM
Bancel StephaneChief Executive OfficerFeb 07Sale23.004,876112,1486,737,237Feb 11 09:51 PM
Bancel StephaneChief Executive OfficerFeb 03Sale20.664,876100,7387,964,465Feb 04 04:09 PM
Bancel StephaneChief Executive OfficerJan 31Sale20.4311,046225,633762,190Feb 03 04:30 PM
Kim Lorence H.Chief Financial OfficerJan 28Sale23.3790021,0331,335,805Jan 29 04:04 PM
Kim Lorence H.Chief Financial OfficerJan 27Sale23.0123,805547,7531,336,705Jan 29 04:04 PM
Hoge StephenPresidentJan 24Sale21.225,000106,1002,076,530Jan 27 04:08 PM
Bancel StephaneChief Executive OfficerJan 24Sale21.2211,046234,396773,236Jan 27 04:03 PM
Hoge StephenPresidentJan 23Sale21.995,000109,9732,081,530Jan 27 04:08 PM
Kim Lorence H.Chief Financial OfficerJan 22Sale23.042,00046,0801,360,510Jan 23 04:18 PM
Bancel StephaneChief Executive OfficerJan 22Sale23.0015,398354,1546,742,113Jan 23 04:17 PM
Bancel StephaneChief Executive OfficerJan 21Sale20.794,850100,8327,966,903Jan 22 04:09 PM
Bancel StephaneChief Executive OfficerJan 17Sale20.9611,046231,524784,282Jan 21 04:15 PM
KANIA EDWIN M JR10% OwnerJan 14Sale20.01117,6252,353,84123,847Jan 14 04:58 PM
Hoge StephenPresidentJan 13Sale19.1410,000191,4002,086,530Jan 14 06:08 PM
Bancel StephaneChief Executive OfficerJan 10Sale20.2416,482333,582795,328Jan 14 05:23 PM
KANIA EDWIN M JR10% OwnerJan 10Sale20.34357,3757,269,972141,472Jan 14 04:58 PM
Bancel StephaneChief Executive OfficerJan 03Sale19.0411,046210,316806,374Jan 06 04:10 PM
Bancel StephaneChief Executive OfficerJan 02Sale19.575,114100,0817,972,046Jan 06 04:10 PM
Bancel StephaneChief Executive OfficerDec 27Sale19.5311,046215,728817,420Jan 03 04:03 PM
Bancel StephaneChief Executive OfficerDec 20Sale19.6911,046217,496828,466Dec 23 04:31 PM
Bancel StephaneChief Executive OfficerDec 13Sale18.5311,046204,682839,512Dec 16 04:46 PM
Zaks Tal ZviChief Medical OfficerDec 12Sale18.54100,0001,854,000104,770Dec 16 07:13 PM
Flagship Ventures Fund IV GeneDirectorDec 11Sale18.65238,3014,445,4578,190,766Dec 11 07:38 PM
KANIA EDWIN M JR10% OwnerDec 10Sale18.81100,0001,880,840498,847Dec 11 07:40 PM
Flagship Ventures Fund IV GeneDirectorDec 10Sale18.9625,417481,8718,229,132Dec 11 07:38 PM
Flagship Ventures Fund IV GeneDirectorDec 09Sale18.99172,1373,269,6078,233,224Dec 11 07:38 PM
Kim Lorence H.Chief Financial OfficerDec 06Option Exercise20.64458,7159,467,8781,601,042Dec 09 07:27 PM
Kim Lorence H.Chief Financial OfficerDec 06Sale20.00238,5324,770,1901,362,510Dec 09 07:27 PM
Bancel StephaneChief Executive OfficerDec 06Sale20.0111,046221,081850,558Dec 09 07:09 PM
Bancel StephaneChief Executive OfficerNov 29Sale20.5411,046226,885861,604Dec 03 07:02 AM
Bancel StephaneChief Executive OfficerNov 22Sale20.4811,046226,222872,650Nov 25 04:08 PM
HUTT PETER BARTONDirectorNov 20Option Exercise0.04200,0008,000203,924Nov 22 06:23 AM
HUTT PETER BARTONDirectorNov 20Sale20.18200,0004,036,0003,924Nov 22 06:23 AM
Bancel StephaneChief Executive OfficerNov 15Sale19.0311,046210,216883,696Nov 19 04:43 PM